Orchev Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.99 M
- Company Age 35 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.80 Cr
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth 6.34%
- Profit Growth -25.31%
- Ebitda -8.25%
- Net Worth 8.86%
- Total Assets 12.52%
About Orchev Pharma
Orchev Pharma Pvt Ltd (OPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 June 1989 and has a history of 35 years and seven months. Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.99 M.
The company currently has active open charges totaling ₹7.80 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kanchanben Bhalodia, Vasantlal Bhalodia, Chirag Patel, and One other member serve as directors at the Company.
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ1989PTC012430
- Company No.
012430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 1989
- Date of AGM
25 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Orchev Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasantlal Bhalodia  | Managing Director | 28-Jun-1989 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanchanben Bhalodia | Director | 03-Oct-1992 | Current |
| Chirag Patel | Director | 01-Aug-2006 | Current |
| Viren Patel | Director | 01-Jun-2006 | Current |
Financial Performance of Orchev Pharma.
Orchev Pharma Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 6.34% increase. The company also saw a substantial fall in profitability, with a 25.31% decrease in profit. The company's net worth moved up by a moderate rise of 8.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orchev Pharma?
In 2023, Orchev Pharma had a promoter holding of 75.50% and a public holding of 24.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mount Ville Farm Houses Private LimitedVasantlal Bhalodia is a mutual person
Charges (Loans)
₹7.80 Cr
₹3.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 7.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2010 | State Bank Of India | ₹7.80 Cr | Open |
| 21 May 2002 | State Bank Of Saurashtra | ₹3.00 Cr | Satisfied |
How Many Employees Work at Orchev Pharma?
Orchev Pharma has a workforce of 43 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orchev Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orchev Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
